149 related articles for article (PubMed ID: 34888042)
1. Roux-en-Y gastric bypass surgery induced oxalosis and acute kidney injury: A case report.
Askari Z; Boskabadi J; Kargar-Soleimanabad S; Gholami F
Ann Med Surg (Lond); 2021 Dec; 72():103088. PubMed ID: 34888042
[TBL] [Abstract][Full Text] [Related]
2. Reversal of Gastric Bypass Resolves Hyperoxaluria and Improves Oxalate Nephropathy Secondary to Roux-en-Y Gastric Bypass.
Agrawal V; Wilfong JB; Rich CE; Gibson PC
Case Rep Nephrol Dial; 2016; 6(3):114-119. PubMed ID: 27781207
[TBL] [Abstract][Full Text] [Related]
3. Medical Management of Advanced Oxalate Nephropathy Secondary to Gastric Bypass Surgery.
Kamel TH; Maroz N
Am J Med Sci; 2021 Apr; 361(4):517-521. PubMed ID: 33187632
[TBL] [Abstract][Full Text] [Related]
4. Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an underrecognized cause of irreversible renal failure.
Nasr SH; D'Agati VD; Said SM; Stokes MB; Largoza MV; Radhakrishnan J; Markowitz GS
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1676-83. PubMed ID: 18701613
[TBL] [Abstract][Full Text] [Related]
5. Steatorrhea and hyperoxaluria occur after gastric bypass surgery in obese rats regardless of dietary fat or oxalate.
Canales BK; Ellen J; Khan SR; Hatch M
J Urol; 2013 Sep; 190(3):1102-9. PubMed ID: 23499748
[TBL] [Abstract][Full Text] [Related]
6. Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass.
Moreland AM; Santa Ana CA; Asplin JR; Kuhn JA; Holmes RP; Cole JA; Odstrcil EA; Van Dinter TG; Martinez JG; Fordtran JS
Gastroenterology; 2017 Apr; 152(5):1055-1067.e3. PubMed ID: 28089681
[TBL] [Abstract][Full Text] [Related]
7. Oxalate nephropathy in a diabetic patient after gastric by-pass.
Moutzouris DA; Skaneli G; Margellos V; Apostolou T; Petraki C; Nikolopoulou N
Clin Nephrol; 2011 Feb; 75 Suppl 1():16-9. PubMed ID: 21269587
[TBL] [Abstract][Full Text] [Related]
8. Reversal of Roux-en-Y Gastric Bypass for Successful Salvage of Renal Allograft.
Hrebinko K; Moroni E; Ganoza A; Puttarajappa CM; Molinari M; Sood P; El Hag M; Wijkstrom M; Tevar AD
Am Surg; 2023 Apr; 89(4):1286-1289. PubMed ID: 33631945
[TBL] [Abstract][Full Text] [Related]
9. "Green Smoothie Cleanse" Causing Acute Oxalate Nephropathy.
Makkapati S; D'Agati VD; Balsam L
Am J Kidney Dis; 2018 Feb; 71(2):281-286. PubMed ID: 29203127
[TBL] [Abstract][Full Text] [Related]
10. Acute oxalate nephropathy due to pancreatic atrophy in newly diagnosed pancreatic carcinoma.
Moinuddin I; Bala A; Ali B; Khan H; Bracamonte E; Sussman A
Hum Pathol; 2016 Feb; 48():163-6. PubMed ID: 26614399
[TBL] [Abstract][Full Text] [Related]
11. Acute Kidney Disease Due to Excessive Vitamin C Ingestion and Remote Roux-en-Y Gastric Bypass Surgery Superimposed on CKD.
Sunkara V; Pelkowski TD; Dreyfus D; Satoskar A
Am J Kidney Dis; 2015 Oct; 66(4):721-4. PubMed ID: 26271145
[TBL] [Abstract][Full Text] [Related]
12. Renal glomerular and tubular injury after gastric bypass in obese rats.
Canales BK; Reyes L; Reinhard MK; Khan SR; Goncalves CG; Meguid MM
Nutrition; 2012 Jan; 28(1):76-80. PubMed ID: 21723091
[TBL] [Abstract][Full Text] [Related]
13. Reversibility of oxalate nephropathy in a kidney transplant recipient with prior gastric bypass surgery.
Sørensen CG; Hvas CL; Thomsen IM; Jespersen B
Clin Kidney J; 2021 May; 14(5):1478-1480. PubMed ID: 34221374
[TBL] [Abstract][Full Text] [Related]
14. The mechanistic basis of hyperoxaluria following gastric bypass in obese rats.
Hatch M; Canales BK
Urolithiasis; 2016 Jun; 44(3):221-30. PubMed ID: 26584912
[TBL] [Abstract][Full Text] [Related]
15. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis.
Duffey BG; Pedro RN; Makhlouf A; Kriedberg C; Stessman M; Hinck B; Ikramuddin S; Kellogg T; Slusarek B; Monga M
J Am Coll Surg; 2008 Jun; 206(6):1145-53. PubMed ID: 18501812
[TBL] [Abstract][Full Text] [Related]
16. Critically ill, tubular injury, delayed early recovery: characteristics of acute kidney disease with renal oxalosis.
Zhou J; Yu X; Su T; Wang S; Yang L
Ren Fail; 2021 Dec; 43(1):425-432. PubMed ID: 33663319
[TBL] [Abstract][Full Text] [Related]
17. Effect of Gastric Bypass vs Best Medical Treatment on Early-Stage Chronic Kidney Disease in Patients With Type 2 Diabetes and Obesity: A Randomized Clinical Trial.
Cohen RV; Pereira TV; Aboud CM; Petry TBZ; Lopes Correa JL; Schiavon CA; Pompílio CE; Pechy FNQ; da Costa Silva ACC; de Melo FLG; Cunha da Silveira LP; de Paris Caravatto PP; Halpern H; Monteiro FLJ; da Costa Martins B; Kuga R; Palumbo TMS; Docherty NG; le Roux CW
JAMA Surg; 2020 Aug; 155(8):e200420. PubMed ID: 32492126
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes and Histological Patterns in Oxalate Nephropathy due to Enteric and Nonenteric Risk Factors.
Reddy S; Bolen E; Abdelmalek M; Lieske JC; Ryan M; Keddis MT
Am J Nephrol; 2021; 52(12):961-968. PubMed ID: 34844241
[TBL] [Abstract][Full Text] [Related]
19. Roux-en-Y gastric bypass is an effective bridge to kidney transplantation: Results from a single center.
Thomas IA; Gaynor JJ; Joseph T; De La Cruz-Munoz N; Sageshima J; Kupin W; Chen LJ; Ciancio G; Burke GW; Mattiazzi AD; Roth D; Guerra G
Clin Transplant; 2018 May; 32(5):e13232. PubMed ID: 29488657
[TBL] [Abstract][Full Text] [Related]
20. Lessons from rodent gastric bypass model of enteric hyperoxaluria.
Kwenda EP; Rabley AK; Canales BK
Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):400-406. PubMed ID: 32398610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
